Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient’s life expectancy, the emphasis is on improving overall quality of life. The key indications covered in this report are cancer pain, oral mucositis, chemotherapy-induced neutropenia (CIN), chemotherapy-induced anemia (CIA), chemotherapy-induced nausea and vomiting (CINV) and bone metastasis. These indications are not only distressing for patients, but can also lead to treatment cessation, which in turn increases patient mortality. As the number of people being diagnosed with cancer grows and access to effective treatment that allows patients to survive longer increases, demand for safe and effective cancer supportive care drugs will rise.
The report details the trend, potential and market size of Cancer Therapeutics and Supportive Care Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Therapeutics and Supportive Care Drugsmarket, defines the market attractiveness level of Cancer Therapeutics and Supportive Care Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cancer Therapeutics and Supportive Care Drugs industry, describes the types of Cancer Therapeutics and Supportive Care Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Therapeutics and Supportive Care Drugs market and the development prospects and opportunities of Cancer Therapeutics and Supportive Care Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Therapeutics and Supportive Care Drugs market in Chapter 13.
By Player:
Johnson & Johnson,
Eli Lilly,
AstraZeneca plc,
Abbott Laboratories,
Bristol-Myers Squibb,
Novartis,
Teva Pharmaceuticals,
By Type:
Cancer Therapeutics
Supportive Care Drugs
By End-User:
Hospital
Retail
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cancer Therapeutics and Supportive Care Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cancer Therapeutics and Supportive Care Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cancer Therapeutics and Supportive Care Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cancer Therapeutics and Supportive Care Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cancer Therapeutics and Supportive Care Drugs Market Analysis and Outlook to 2022
-
7.1 Global Cancer Therapeutics and Supportive Care Drugs Consumption (2017-2022)
-
7.2 United States Cancer Therapeutics and Supportive Care Drugs Consumption (2017-2022)
-
7.3 Europe Cancer Therapeutics and Supportive Care Drugs Consumption (2017-2022)
-
7.4 China Cancer Therapeutics and Supportive Care Drugs Consumption (2017-2022)
-
7.5 Japan Cancer Therapeutics and Supportive Care Drugs Consumption (2017-2022)
-
7.6 India Cancer Therapeutics and Supportive Care Drugs Consumption (2017-2022)
-
7.7 South Korea Cancer Therapeutics and Supportive Care Drugs Consumption (2017-2022)
8 Region and Country-wise Cancer Therapeutics and Supportive Care Drugs Market Analysis and Outlook to 2028
-
8.1 Global Cancer Therapeutics and Supportive Care Drugs Consumption Forecast (2022-2028)
-
8.2 United States Cancer Therapeutics and Supportive Care Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Cancer Therapeutics and Supportive Care Drugs Consumption Forecast (2022-2028)
-
8.4 China Cancer Therapeutics and Supportive Care Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Cancer Therapeutics and Supportive Care Drugs Consumption Forecast (2022-2028)
-
8.6 India Cancer Therapeutics and Supportive Care Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Cancer Therapeutics and Supportive Care Drugs Consumption Forecast (2022-2028)
9 Global Cancer Therapeutics and Supportive Care Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Cancer Therapeutics and Supportive Care Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Cancer Therapeutics Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Supportive Care Drugs Consumption and Growth Rate (2017-2022)
-
9.2 Global Cancer Therapeutics and Supportive Care Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Consumption and Growth Rate (2017-2022)
10 Global Cancer Therapeutics and Supportive Care Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Cancer Therapeutics and Supportive Care Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Supportive Care Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cancer Therapeutics and Supportive Care Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Consumption Forecast and Growth Rate (2022-2028)
11 Global Cancer Therapeutics and Supportive Care Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cancer Therapeutics and Supportive Care Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cancer Therapeutics and Supportive Care Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cancer Therapeutics and Supportive Care Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cancer Therapeutics and Supportive Care Drugs Market Competitive Analysis
-
14.1 Johnson & Johnson,
-
14.1.1 Johnson & Johnson, Company Details
-
14.1.2 Johnson & Johnson, Cancer Therapeutics and Supportive Care Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Johnson & Johnson, Cancer Therapeutics and Supportive Care Drugs Product and Service
-
14.2 Eli Lilly,
-
14.2.1 Eli Lilly, Company Details
-
14.2.2 Eli Lilly, Cancer Therapeutics and Supportive Care Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Eli Lilly, Cancer Therapeutics and Supportive Care Drugs Product and Service
-
14.3 AstraZeneca plc,
-
14.3.1 AstraZeneca plc, Company Details
-
14.3.2 AstraZeneca plc, Cancer Therapeutics and Supportive Care Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 AstraZeneca plc, Cancer Therapeutics and Supportive Care Drugs Product and Service
-
14.4 Abbott Laboratories,
-
14.4.1 Abbott Laboratories, Company Details
-
14.4.2 Abbott Laboratories, Cancer Therapeutics and Supportive Care Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Abbott Laboratories, Cancer Therapeutics and Supportive Care Drugs Product and Service
-
14.5 Bristol-Myers Squibb,
-
14.5.1 Bristol-Myers Squibb, Company Details
-
14.5.2 Bristol-Myers Squibb, Cancer Therapeutics and Supportive Care Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bristol-Myers Squibb, Cancer Therapeutics and Supportive Care Drugs Product and Service
-
14.6 Novartis,
-
14.6.1 Novartis, Company Details
-
14.6.2 Novartis, Cancer Therapeutics and Supportive Care Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis, Cancer Therapeutics and Supportive Care Drugs Product and Service
-
14.7 Teva Pharmaceuticals,
-
14.7.1 Teva Pharmaceuticals, Company Details
-
14.7.2 Teva Pharmaceuticals, Cancer Therapeutics and Supportive Care Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Teva Pharmaceuticals, Cancer Therapeutics and Supportive Care Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cancer Therapeutics and Supportive Care Drugs
-
Figure Cancer Therapeutics and Supportive Care Drugs Picture
-
Table Global Cancer Therapeutics and Supportive Care Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Therapeutics and Supportive Care Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Therapeutics and Supportive Care Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cancer Therapeutics and Supportive Care Drugs Consumption by Country (2017-2022)
-
Figure United States Cancer Therapeutics and Supportive Care Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Cancer Therapeutics and Supportive Care Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Cancer Therapeutics and Supportive Care Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Cancer Therapeutics and Supportive Care Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Cancer Therapeutics and Supportive Care Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cancer Therapeutics and Supportive Care Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Therapeutics and Supportive Care Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Cancer Therapeutics and Supportive Care Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cancer Therapeutics and Supportive Care Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cancer Therapeutics and Supportive Care Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cancer Therapeutics and Supportive Care Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cancer Therapeutics and Supportive Care Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cancer Therapeutics and Supportive Care Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Supportive Care Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Supportive Care Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cancer Therapeutics and Supportive Care Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cancer Therapeutics and Supportive Care Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Johnson & Johnson, (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson, Cancer Therapeutics and Supportive Care Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson, Cancer Therapeutics and Supportive Care Drugs Product and Service
-
Table Eli Lilly, (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly, Cancer Therapeutics and Supportive Care Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly, Cancer Therapeutics and Supportive Care Drugs Product and Service
-
Table AstraZeneca plc, (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca plc, Cancer Therapeutics and Supportive Care Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca plc, Cancer Therapeutics and Supportive Care Drugs Product and Service
-
Table Abbott Laboratories, (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories, Cancer Therapeutics and Supportive Care Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories, Cancer Therapeutics and Supportive Care Drugs Product and Service
-
Table Bristol-Myers Squibb, (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb, Cancer Therapeutics and Supportive Care Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb, Cancer Therapeutics and Supportive Care Drugs Product and Service
-
Table Novartis, (Foundation Year, Company Profile and etc.)
-
Table Novartis, Cancer Therapeutics and Supportive Care Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis, Cancer Therapeutics and Supportive Care Drugs Product and Service
-
Table Teva Pharmaceuticals, (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceuticals, Cancer Therapeutics and Supportive Care Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceuticals, Cancer Therapeutics and Supportive Care Drugs Product and Service
-
